Avalo Therapeutics (AVTX) Return on Equity (ROE) (2015 - 2025)
Avalo Therapeutics (AVTX) Return on Equity (ROE) from Sep 30, 2015 to Dec 31, 2025. The TTM Avalo Therapeutics (AVTX) Return on Equity (ROE) is -16.52%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Avalo Therapeutics (AVTX)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | -94.23% | +256.84% |
| 2024 | -26.41% | -93.89% |
| 2023 | -432.05% | -213.15% |
| 2022 | 381.85% | -204.45% |
| 2021 | -365.60% | +41.40% |
| 2020 | -258.55% | +237.87% |
| 2019 | -76.52% | -60.05% |
| 2018 | -191.54% | -549.55% |
| 2017 | 42.61% | -100.54% |
| 2016 | -7842.86% | +9679.27% |
| 2015 | -80.20% | -231.48% |
| 2014 | 61.00% | -16.57% |
| 2013 | 73.11% | N/A |